Good Lifestyle

In the United States, a person dies from cardiovascular disease every 34 seconds , according to the centers for Disease Control and Prevention. Regarding questions close to the heart, lifestyle and food changes can make all the difference. But prevention is just as important.

Earlier this week, Best life reported on a new AI tool that can detect breast cancer , and now scientists use similar technology to diagnose cases of heart disease - and this has experienced significant success.

In relation: Taking 1 common medication could prevent 100,000 heart attacks per year, research reveals research .

A new AI tool can detect hidden heart disease.

In the breakdown of the new hearts, biomedical researchers have developed a screening tool powered by AI which can detect hidden heart disease. This is the first of its kind and is designed to be used in tandem with electrocardiograms (ECG).

"We have colonoscopies, we have mammograms, but we have no equivalents for most forms of heart disease", " Pierre Elias , Study author and assistant professor of biomedical medicine and computer science at the Columbia University Vacelos College of Physicians and Surgeons, and the medical director of artificial intelligence in NewYork-Presbyterian, in A press release .

The screening tool powered by AI in question is called Echonext.

It analyzes ECG data and identifies patients who should undergo additional tests, such as an echocardiogram, for potential structural heart problems. These occur when there is "an anomaly in the structure or function of valves, walls, bedrooms or muscles in your heart", explains Cleveland clinic .

Examples include:

• Valve disease
• Congenital heart disease
• Railed heart function
• Cardiomyopathy

Structural heart problems may have serious health risks; However, many cases are not detected until a catastrophic event occurs. Echonext can change that. The researchers reported that echonctors "identified with precision the structural heart disease of ECG readings more often than cardiologists".

Their results were published in the journal Nature .

In relation: 3 heart tests A cardiologist says you should never jump .

How Echonext is accompanied by electrocardiograms:

An ECG is a standard test used by cardiologists to measure electrical signals in the heart as well as your heart rate, explains Mayo clinic . It can collect irregular cardiac beats (arrhythmias), signs of blocking or narrowing in the arteries, and damage caused by previous heart attacks. Because the test is so easy and quick (and painless), the doctor will usually pass your results on site.

The ECGs are routine in cardiology, although there are exceptions. "We have all learned at the medical school that you cannot detect structural heart diseases from an electrocardiogram," said Elias.

This is where Echonext comes into play. The screening tool was "designed to analyze ordinary ECG data to determine when the monitoring monitoring is justified," said Elias.

Researchers have formed the model using more than 1.2 million ECG echocardiogram files of 230,000 patients.

In relation: 85% of non -vaccinated women will probably get this virus - and a new research connects it to heart disease .

Echonext constantly surpasses human detection.

In a study evaluating the reliability of the tool, the researchers noted that the Echonxe "has demonstrated great precision in the identification of structural cardiac problems, including heart failure due to cardiomyopathy, valve disease, pulmonary hypertension and severe thickening of the heart."

Echonext also surpasses cardiologists to detect 20%structural heart problems. In a study examining 3,200 ECGs, the tool fueled by AI had a success rate of 77%, while a team of 13 doctors had a precision of 64%.

"Echonext mainly uses the cheaper test to understand who needs more expensive ultrasound," said Elias. "It detects diseases that cardiologists cannot start from an ECG. We think that the ECG Plus has the potential to create a brand new screening paradigm."

More recently, researchers have used Echonext to filter 85,000 ECG patients for structural heart problems. Echonext classified more than 7,500 people at high risk for unmatched structural heart disease, and 55% were then recommended by their doctor to undergo an echocardiogram.

"Among these, almost three -quarters have been diagnosed with structural heart disease - twice the positivity rate compared to all people with their first echocardiogram without AI profit," the authors wrote.

"Using our technology, we may be able to transform the estimated 400 million ECGs that will be carried out worldwide this year in 400 million chances of projecting structural heart disease and potentially offer vital treatment at the most appropriate time," said Elias.

As for what Echonext reaches hospitals in the country, Elias and his research team are currently carrying out a clinical trial in eight emergency services.